Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / draft-answer-affirmative-defenses.docx
draft-answer-affirmative-defenses.docx
Parties
Harkness LLP
Defendant Penterra Pharmaceuticals Corp
STATEMENT Defendant Penterra Pharmaceuticals Corp
Penterra Pharmaceuticals Corp
Tidewater Registered Agents LLC
Cole LLP
Ridgeway Partners LLC
Capitol Corp
Dates
November 1, 2024
June 10, 2024
August 14, 2024
August 22, 2024
September 6, 2024
September 27, 2024
September 30, 2024
December 10, 2024
December 31, 2023
June 30, 2024
Amounts
$900,000,000
$87.3
$87,300,000
$14,200,000,000
$4,870,000,000
$2,100,000,000
$14.2
$850,000,000
$950,000,000
$280,500
Obligations
2(b) provides that, as a separate condition to Buyer's obligation to consummate the closing, since the date of the Agreement, no Material Adverse Effect shall have occurred that is continuing as of the Closing Date
2(b) of the SPA required, as a separate and independent condition to Buyer's obligation to consummate the closing, that no Material Adverse Effect shall have occurred since the date of the Agreement (June 10, 2024) that was continuing as of the Closing Date
Accordingly, Veridian has not met, and cannot meet, the contractual prerequisite for seeking specific performance, and any claim for specific performance must be denied